Pentachlorophenol

Pentachlorophenol

SCHEMBL139992

Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl.[PbH2]

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 8/20 0.91
TSHR P16473 7/20 0.91
HPGD P15428 7/20 0.91
ALDH1A1 P00352 3/20 0.91
MEN1 O00255 2/20 0.91
LMNA P02545 2/20 0.91
MAPT P10636 2/20 0.91
KMT2A Q03164 2/20 0.91
CYP1A2 P05177 4/20 0.50
CYP2C9 P11712 4/20 0.50
HIF1A Q16665 3/20 0.50
CASP1 P29466 1/20 0.47
CYP2C19 P33261 1/20 0.43
MAPK1 P28482 3/20 0.42
CYP3A4 P08684 5/20 0.40
USP2 O75604 1/20 0.40
TP53 P04637 1/20 0.40
GLA P06280 1/20 0.40
THRB P10828 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pentachlorophenol SCHEMBL1492 0.95 HSD17B10 (1.00) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL23121452 0.95 HSD17B10 (1.00) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL5315995 0.95 HSD17B10 (1.00) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL1330735 0.95 HSD17B10 (1.00) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL3751225 0.91 HSD17B10 (0.91) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL21177789 0.91 HSD17B10 (0.91) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL21647360 0.91 HSD17B10 (0.91) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL22027593 0.91 HSD17B10 (0.91) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL11459279 0.91 HSD17B10 (0.91) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL5167937 0.91 HSD17B10 (0.91) HSD17B10TSHRHPGDALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150289916-A1 BONE SCREWS HAVING MORE THAN THREE LEADS SHARPS CHESTER H (US) 2015-10-15 US claimed
CN-116571222-B Pentachlorophenol surface imprinting magnetic microsphere and preparation method thereof 北京建工环境修复股份有限公司 2023-09-26 CN disclosed
CN-116441555-B Functionalized gold nanorod probe, preparation method and application thereof in pentachlorophenol dark field microscopic imaging detection 北京建工环境修复股份有限公司 2023-08-22 CN disclosed
CN-116571222-A Pentachlorophenol surface imprinting magnetic microsphere and preparation method thereof 北京建工环境修复股份有限公司 2023-08-11 CN disclosed
CN-116441555-A Functionalized gold nanorod probe, preparation method and application thereof in pentachlorophenol dark field microscopic imaging detection 北京建工环境修复股份有限公司 2023-07-18 CN disclosed
US-11027131-B2 Use of a new stimulation design to treat neurological disorders DE RIDDER DIRK (NZ) 2021-06-08 US disclosed
EP-3459591-A1 USE OF A NEW STIMULATION DESIGN TO TREAT NEUROLOGICAL DISORDER De Ridder, Dirk (BE) 2019-03-27 EP disclosed
US-20180304083-A1 USE OF A NEW STIMULATION DESIGN TO TREAT NEUROLOGICAL DISORDERS DE RIDDER DIRK (NZ) 2018-10-25 US disclosed
EP-2611497-B1 A NEW STIMULATION DESIGN TO TREAT NEUROLOGICAL DISORDER DE RIDDER DIRK (BE) 2018-09-19 EP disclosed
US-10035021-B2 Use of a new stimulation design to treat neurological disorder DE RIDDER DIRK (NZ) 2018-07-31 US disclosed
US-20150289916-A1 BONE SCREWS HAVING MORE THAN THREE LEADS SHARPS CHESTER H (US) 2015-10-15 US disclosed
US-20150289916-A1 BONE SCREWS HAVING MORE THAN THREE LEADS SHARPS CHESTER H (US) 2015-10-15 US disclosed
US-20140155960-A1 USE OF A NEW STIMULATION DESIGN TO TREAT NEUROLOGICAL DISORDER DE RIDDER DIRK (BE) 2014-06-05 US disclosed
US-8682441-B2 Use of a new stimulation design to treat neurological disorder Advanced Neurostimulation Systems, Inc. (US) 2014-03-25 US disclosed
US-8612009-B2 Method of neurostimulation of distinct neural structures using single paddle lead to treat multiple pain locations and multi-column, multi-row paddle lead for such neurostimulation ADVANCED NEUROMODULATION SYSTEMS, INC. (US) 2013-12-17 US disclosed
EP-2611497-A1 USE OF A NEW STIMULATION DESIGN TO TREAT NEUROLOGICAL DISORDER De Ridder, Dirk (BE) 2013-07-10 EP disclosed
US-20120203301-A1 METHODS USING TRIGEMINAL NERVE STIMULATION TO TREAT NEUROLOGICAL DISEASES ADVANCED NEUROMODULATION SYSTEMS, INC. (US) 2012-08-09 US disclosed
US-20120059438-A1 USE OF A NEW STIMULATION DESIGN TO TREAT NEUROLOGICAL DISORDER DE RIDDER DIRK (US) 2012-03-08 US disclosed
WO-2012030831-A1 USE OF A NEW STIMULATION DESIGN TO TREAT NEUROLOGICAL DISORDER ADVANCED NEUROMODULATION SYSTEMS, INC. (US) 2012-03-08 WO disclosed
US-20120016453-A1 METHOD OF NEUROSTIMULATION OF DISTINCT NEURAL STRUCTURES USING SINGLE PADDLE LEAD TO TREAT MULTIPLE PAIN LOCATIONS AND MULTI-COLUMN, MULTI-ROW PADDLE LEAD FOR SUCH NEUROSTIMULATION FELER CLAUDIO A (US) 2012-01-19 US disclosed